Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2013

01.12.2013 | Original Research

Weight Loss Success in Metabolic Syndrome by Telephone Interventions: Results from the SHINE Study

verfasst von: Ruth S. Weinstock, MD, PhD, Paula M. Trief, PhD, Donald Cibula, PhD, Philip C. Morin, MS, Linda M. Delahanty, MS, RD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

The Diabetes Prevention Program (DPP) intensive lifestyle intervention resulted in significant weight loss, reducing the development of diabetes, but needs to be adapted to primary care provider (PCP) practices.

OBJECTIVES

To compare a DPP-translation using individual (IC) vs. conference (CC) calls delivered by PCP staff for the outcome of percent weight loss over 2 years.

DESIGN

Randomized clinical trial.

SETTING

Five PCP sites.

PARTICIPANTS

Obese patients with metabolic syndrome, without diabetes (IC, n = 129; CC, n = 128).

INTERVENTION

Telephone delivery of the DPP Lifestyle Balance intervention [16-session core curriculum in year 1, 12-session continued telephone contact in year 2 plus telephone coaching sessions (dietitians).

MAIN MEASURES

Weight (kg), body mass index (BMI), and waist circumference.

KEY RESULTS

Baseline data: age = 52 years, BMI = 39 kg/m2, 75 % female, 85 % non-Hispanic White, 13 % non-Hispanic Black, and 48 % annual incomes <$40,000/year. In the intention-to-treat analyses at year 2, mean percent weight loss was −5.6 % (CC, p < 0.001) and −1.8 % (IC, p = 0.046) and was greater for CC than for IC (p = 0.016). At year 2, mean weight loss was 6.2 kg (CC) and 2.2 kg (IC) (p < 0.001). There was similar weight loss at year 1, but between year 1 and year 2 CC participants continued to lose while IC participants regained. At year 2, 52 % and 43 % (CC) and 29 % and 22 % (IC) of participants lost at least 5 % and 7 % of initial weight. BMI also decreased more for CC than IC (−2.1 kg/m2 vs. −0.8 kg/m2 p < 0.001). Waist circumference decreased by 3.1 cm (CC) and 2.4 cm (IC) at year 2. Completers (≥9 of 16 sessions; mean 13.3 sessions) lost significantly more weight than non-completers (mean 4.3 sessions).

CONCLUSIONS

PCP staff delivery of the DPP lifestyle intervention by telephone can be effective in achieving weight loss in obese people with metabolic syndrome. Greater weight loss may be attained with a group telephone intervention.
Literatur
1.
Zurück zum Zitat Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–219.PubMedCrossRef Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–219.PubMedCrossRef
2.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, for the Diabetes Prevention Program Research Group, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, for the Diabetes Prevention Program Research Group, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef
3.
Zurück zum Zitat Knowler WC, Fowler SE, Hamman RF, for the Diabetes Prevention Program Research Group, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.PubMedCrossRef Knowler WC, Fowler SE, Hamman RF, for the Diabetes Prevention Program Research Group, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.PubMedCrossRef
4.
Zurück zum Zitat Herman WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003;26:36–47.CrossRef Herman WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003;26:36–47.CrossRef
5.
Zurück zum Zitat Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, for the Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142:611–619.PubMedCrossRef Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, for the Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142:611–619.PubMedCrossRef
6.
Zurück zum Zitat Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Affairs. 2012;31:67–75.PubMedCrossRef Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Affairs. 2012;31:67–75.PubMedCrossRef
7.
Zurück zum Zitat Katula JA, Vitolins MZ, Rosenberger CS, et al. One-year results of a community-based translation of the Diabetes Prevention Program. Healthy-living partnerships to prevent diabetes (HELP PD) project. Diabetes Care. 2011;34:1451–1457.PubMedCrossRef Katula JA, Vitolins MZ, Rosenberger CS, et al. One-year results of a community-based translation of the Diabetes Prevention Program. Healthy-living partnerships to prevent diabetes (HELP PD) project. Diabetes Care. 2011;34:1451–1457.PubMedCrossRef
8.
Zurück zum Zitat Ackermann RT, Finch EA, Caffrey HM, et al. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic illness. 2011;7:279–290.PubMedCrossRef Ackermann RT, Finch EA, Caffrey HM, et al. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic illness. 2011;7:279–290.PubMedCrossRef
9.
Zurück zum Zitat Boltri JM, Davis-Smith M, Okosun IS, et al. Translation of the National Institutes of Health Diabetes Prevention Program in African American churches. J Natl Med Assoc. 2011;103:194–202.PubMed Boltri JM, Davis-Smith M, Okosun IS, et al. Translation of the National Institutes of Health Diabetes Prevention Program in African American churches. J Natl Med Assoc. 2011;103:194–202.PubMed
11.
Zurück zum Zitat Smith AW, Borowski LA, Liu B, et al. US primary care physicians’ diet-, physical activity-, and weight-related care of adult patients. Am J Prev Med. 2011;41:33–42.PubMedCrossRef Smith AW, Borowski LA, Liu B, et al. US primary care physicians’ diet-, physical activity-, and weight-related care of adult patients. Am J Prev Med. 2011;41:33–42.PubMedCrossRef
12.
Zurück zum Zitat Ross R, Lam L, Blair SN, et al. Trial of prevention and reduction of obesity through active living in clinical settings: A randomized controlled trial. Arch Intern Med. 2012;172:414–424.PubMedCrossRef Ross R, Lam L, Blair SN, et al. Trial of prevention and reduction of obesity through active living in clinical settings: A randomized controlled trial. Arch Intern Med. 2012;172:414–424.PubMedCrossRef
13.
Zurück zum Zitat Wadden TA, Volger S, Sarwer DB, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365:1969–1979.PubMedCrossRef Wadden TA, Volger S, Sarwer DB, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365:1969–1979.PubMedCrossRef
14.
Zurück zum Zitat Kushner RF. Barriers to providing nutrition counseling by physicians: A survey of primary care practitioners. Prev Med. 1995;24:546–552.PubMedCrossRef Kushner RF. Barriers to providing nutrition counseling by physicians: A survey of primary care practitioners. Prev Med. 1995;24:546–552.PubMedCrossRef
15.
Zurück zum Zitat Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med. 2009;24:1073–1079.PubMedCrossRef Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med. 2009;24:1073–1079.PubMedCrossRef
16.
Zurück zum Zitat Ciao AC, Latner JD, Durso LE. Treatment seeking and barriers to weight loss treatments of different intensity levels among obese and overweight individuals. Eating and Weight Disorders. 2012;17:e9–16.PubMedCrossRef Ciao AC, Latner JD, Durso LE. Treatment seeking and barriers to weight loss treatments of different intensity levels among obese and overweight individuals. Eating and Weight Disorders. 2012;17:e9–16.PubMedCrossRef
17.
Zurück zum Zitat Renjilian DA, Perri MG, Nezu AM, et al. Individual vs. group therapy for obesity: Effects of matching participants to their treatment preference. J Consult Clin Psychol. 2001;69:717–721.PubMedCrossRef Renjilian DA, Perri MG, Nezu AM, et al. Individual vs. group therapy for obesity: Effects of matching participants to their treatment preference. J Consult Clin Psychol. 2001;69:717–721.PubMedCrossRef
18.
Zurück zum Zitat Cresci B, Tesi F, La Ferlita T, Ricca V, et al. Group versus individual cognitive-behavioral treatment for obesity: Results after 36 months. Eat Weight Disord. 2007;12:147–153.PubMedCrossRef Cresci B, Tesi F, La Ferlita T, Ricca V, et al. Group versus individual cognitive-behavioral treatment for obesity: Results after 36 months. Eat Weight Disord. 2007;12:147–153.PubMedCrossRef
19.
Zurück zum Zitat Befort CA, Donnelly JE, Sullivan DK, et al. Group versus individual phone-based obesity treatment for rural women. Eating Behaviors. 2010;11:11–17.PubMedCrossRef Befort CA, Donnelly JE, Sullivan DK, et al. Group versus individual phone-based obesity treatment for rural women. Eating Behaviors. 2010;11:11–17.PubMedCrossRef
20.
Zurück zum Zitat The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care. 2002;25:2165–2171.CrossRef The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care. 2002;25:2165–2171.CrossRef
21.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–1062.PubMedCrossRef Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–1062.PubMedCrossRef
22.
Zurück zum Zitat Williamson DF, Marrero DG. Scaling up type 2 diabetes prevention programs for high risk persons: progress and challenges in the United States. In: Schwarz P, Reddy P, Greaves C, Dunbar JA, Schwarz J, eds. Diabetes prevention in practice. Dresden: TIMAINI Institute for Prevention Management; 2010:69–82. Williamson DF, Marrero DG. Scaling up type 2 diabetes prevention programs for high risk persons: progress and challenges in the United States. In: Schwarz P, Reddy P, Greaves C, Dunbar JA, Schwarz J, eds. Diabetes prevention in practice. Dresden: TIMAINI Institute for Prevention Management; 2010:69–82.
23.
Zurück zum Zitat The Diabetes Prevention Program Research Group. Baseline characteristics of the randomized cohort. Diabetes Care. 2000;23:1619–1629.CrossRef The Diabetes Prevention Program Research Group. Baseline characteristics of the randomized cohort. Diabetes Care. 2000;23:1619–1629.CrossRef
24.
Zurück zum Zitat Appel LJ, Clark JM, Yeh H-C, et al. Comparative effectiveness in weight-loss interventions in clinical practice. N Engl J Med. 2011;365:1959–1968.PubMedCrossRef Appel LJ, Clark JM, Yeh H-C, et al. Comparative effectiveness in weight-loss interventions in clinical practice. N Engl J Med. 2011;365:1959–1968.PubMedCrossRef
25.
Zurück zum Zitat Bennett GG, Warner ET, Glasgow RE, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012;172:565–574.PubMedCrossRef Bennett GG, Warner ET, Glasgow RE, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012;172:565–574.PubMedCrossRef
26.
Zurück zum Zitat Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: A starting point for continuous improvement. Brit J Gen Pract. 2008;58:548–554.CrossRef Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: A starting point for continuous improvement. Brit J Gen Pract. 2008;58:548–554.CrossRef
Metadaten
Titel
Weight Loss Success in Metabolic Syndrome by Telephone Interventions: Results from the SHINE Study
verfasst von
Ruth S. Weinstock, MD, PhD
Paula M. Trief, PhD
Donald Cibula, PhD
Philip C. Morin, MS
Linda M. Delahanty, MS, RD
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2013
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2529-7

Weitere Artikel der Ausgabe 12/2013

Journal of General Internal Medicine 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.